abstract |
Certain novel piperazine urea derivatives are agonists of the human melanocortin-4 receptor (MC-4R), in particular the receptor subtype selective agonist of MC-4R. They are useful in the treatment, management or prevention of diseases and disorders that respond to activation of MC-4R, such as obesity and diabetes. |